Introduction contribute toward expression of the 2Њ cell fate. The remaining vulval precursor cells (P3.p, P4.p, and P8.p) The receptor tyrosine kinase (RTK)/Ras/MAP kinase sigdo not receive either the anchor cell signal or the lateral naling cascade is an evolutionarily conserved signaling signal and consequently express the nonvulval, 3Њ cell pathway that controls key developmental processes, fate. such as neuronal differentiation, fibroblast proliferation, In this report, we have focused on two genes (lin-31 and cell-type specification (reviewed in Schlessinger and lin-1) that act downstream of mpk-1. lin-31 encodes and Ullrich, 1992) . MAP kinases act at the end of this a winged helix (WH) transcription factor similar to mamsignaling pathway; upon activation, MAP kinases transmalian HNF-3 and Drosophila melanogaster forkhead locate into the nucleus and phosphorylate transcription (Miller et al., 1993) . lin-31 null mutants exhibit both a factors (reviewed in Treisman, 1996) . These transcrippartially penetrant vulvaless (Vul) and multivulva (Muv) tion factor targets form crucial links between the prophenotype. Specifically, in about 40% of lin-31 mutant cesses of intercellular signaling and gene expression, animals, either P5.p, P6.p, or P7.p adopts the 3Њ nonvuland they may directly mediate how a cell responds to val fate instead of the normal 1Њ or 2Њ vulval fate, resulting activation of the MAP kinase signaling pathway. Thus, in a vulvaless (Vul) phenotype. Conversely, in about 61% it is important to identify functional targets of MAP kiof lin-31 mutant animals, either P3.p, P4.p, or P8.p adopts nase and to determine how phosphorylation of these the 1Њ or 2Њ vulval fate instead of the normal 3Њ nonvulval substrates regulates cell fate specification.
fate, resulting in a multivulva (Muv) phenotype. This muAnother key point to understand is the molecular basis tant phenotype suggests that LIN-31 may possess two underlying signaling specificity (reviewed in Marshall, activities: one that inhibits vulval induction (in P3.p, P4.p, 1995) . The MAP kinase signaling pathway acts in many and P8.p) and another that promotes vulval induction cell types during development and yet is able to induce (in P5.p, P6.p, and P7.p) . specific and distinct cellular responses in each of these lin-1 encodes an Ets-related transcription factor and cell types. How can a generally used signaling pathway acts as an inhibitor of vulval cell fates (Beitel et al., 1995) . elicit different responses in distinct tissue types? One
In lin-1 mutants, most vulval precursor cells express 1Њ attractive hypothesis is that there may exist tissue-speor 2Њ vulval fates, resulting in a Muv phenotype (Kornfeld, cific targets of the MAP kinase signaling cascade and 1997). In wild-type animals, activation of the LET-23 RTK/MPK-1 signaling pathway in P6.p may inactivate LIN-1 function, allowing this cell to express a vulval fate.
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involved in the development of the excretory system, the male tail, and the posterior ectoderm (Ferguson and vulvaless (Vul) et al., 1991) . To determine whether MAP kinase can directly phosphorylate LIN-31 or LIN-1, we performed sues to be controlled by similar upstream signals, and it may permit common signaling pathways to trigger in vitro phosphorylation experiments by incubating activated rat ERK2 with purified GST-LIN-31 or epitopedistinct developmental programs and cell fate choices.
tagged FLAG-LIN-1. As rat ERK2 can functionally rescue the mpk-1 mutant phenotype in transformation experiResults ments (Wu and Han, 1994) , it is likely that rat ERK2 can recognize the substrates that are normally phosphorylin-31 WH Acts Downstream of mpk-1 We analyzed the phenotype of a lin-31 mpk-1 double lated by C. elegans MPK-1. We found that both GST-LIN-31 and FLAG-LIN-1 were efficiently phosphorylated mutant to determine whether lin-31 WH acts downstream of mpk-1 (Figure 1) . mpk-1(null) mutants have a by ERK2 in vitro (Figures 2A and 2B ). We then used To determine whether MAP kinase might phosphoryTo determine whether LIN-31 binds to LIN-1 in vivo, we coinfected insect Sf9 cells with recombinant baculolate LIN-31 and LIN-1 in vivo, NIH 3T3 fibroblasts were transfected with vectors expressing either epitopeviruses encoding GST-LIN-31 and epitope-tagged FLAG-LIN-1. GST-LIN-31 protein was then purified from wholetagged versions of LIN-31, nonphosphorylatable LIN-31(PhD), or LIN-1. These cells were then stimulated by cell lysates, and the presence of FLAG-LIN-1 in the GST-LIN-31 complex was determined using ␣-FLAG anticotransfecting them with vectors expressing either constitutively activated H-Ras (G12V) or constitutively actibodies in Western blotting experiments. This experiment revealed that FLAG-LIN-1 associated with GST-LIN-31 vated MEK1 (⌬N3, S222D). Both activated proteins have previously been shown to stimulate MAP kinase (ERK1 ( Figure 3A) but not with the Drosophila USP transcription factor (GST-USP), indicating that the association of and ERK2) activity in vivo (Leevers and Marshall, 1992; Mansour et al., 1994) , and in particular, MEK1 is believed LIN-1 with LIN-31 is specific. We also performed this experiment in reverse and found that LIN-31 specifically to act as a highly specific activator of ERK1 and ERK2 (Robbins et al., 1993) . Stimulation by activated H-Ras coimmunprecipitated with LIN-1 (data not shown). These results show that LIN-1 specifically copurifies with LINor activated MEK1 caused a substantial portion of LIN-31 protein to display a reduced electrophoretic mobility 31 when coexpressed in insect cells.
To determine whether LIN-31 can directly bind to on SDS-PAGE gels ( Figure 2C ). This mobility shift was not seen in cells expressing LIN-31(PhD), suggesting LIN-1, we performed in vitro binding experiments using independently purified GST-LIN-31 and FLAG-LIN-1. As that it is most likely due to phosphorylation. Similarly, stimulation by activated H-Ras or activated MEK1 caused seen in Figure 3B , FLAG-LIN-1 bound to GST-LIN-31 in vitro. We then defined the region of LIN-31 that contains LIN-1 to migrate as a slower and more compact band on SDS-PAGE gels ( Figure 2D ), similar to the shift observed the LIN-1-binding site. GST-LIN-31 fusion proteins containing the LIN-31 DNA-binding domain, the middle rewhen LIN-1 is phosphorylated by MAP kinase in vitro. These results indicate that both LIN-31 and LIN-1 are gion of LIN-31, and the C terminus of LIN-31 were made in bacteria and tested for their ability to bind to FLAGlikely to be phosphorylated by the MAP kinases ERK1 or ERK2 in NIH 3T3 cells.
LIN-1 in vitro ( Figure 3B ). The middle region (amino acids To test whether MAP kinase might regulate the activity of LIN-31 WH and LIN-1 Ets by affecting their binding to FLAG-LIN-1 under the same binding conditions. Interestingly, this 130 amino acid middle region of LIN-31 that interaction, purified GST-LIN-31 and FLAG-LIN-1 proteins were incubated together in the presence of activated binds LIN-1 also contains a MAP kinase phosphorylation site (Thr-145) and may be a transcriptional activation MAP kinase and ATP. Phosphorylated GST-LIN-31 was recovered and assayed for bound phosphorylated FLAGdomain, since it is acidic and proline-rich. LIN-1. This experiment revealed that MAP kinase phos-LIN-1/LIN-31 inhibitor complex, phosphorylated LIN-31 could also actively promote the expression of vulval cell phorylation substantially reduced the amount of FLAG-LIN-1 bound to GST-LIN-31 in vitro ( Figure 3C ).
fates. This is because lin-31 loss-of-function mutants also exhibit a partial Vul phenotype (indicating a function We then determined whether MAP kinase phosphorylation of either factor alone was sufficient to prevent in promoting vulval cell fates). In the following sections, we use three different lin-31 constructs to test predicformation of the LIN-1/LIN-31 complex. Phosphorylated GST-LIN-31 and FLAG-LIN-1 were generated indepentions of this model. If the LIN-1/LIN-31 complex inhibits vulval induction, dently by preincubating each purified protein with MAP kinase. Phosphorylated GST-LIN-31 was then bound to then maintaining this complex in each of the vulval precursor cells should result in constitutive vulval inhibition. glutathione beads, and phosphorylated FLAG-LIN-1 was bound to ␣-FLAG beads. Bound phosphorylated protein
To test this prediction, we constructed a LIN-1/LIN-31 forced heterodimer by engineering a transgene that uses was mixed with its unphosphorylated partner (phosphorylated GST-LIN-31 with unphosphorylated FLAGthe lin-31 promoter to express a single polypeptide containing the entire lin-1 coding sequence followed by the LIN-1, and vice versa), and binding between the two proteins was assayed. Phosphorylation of LIN-31, but entire lin-31 coding sequence (termed LIN-1::LIN-31). not LIN-1, disrupted formation of the LIN-1/LIN-31 complex. Specifically, we found that phosphorylated LIN-31 
lin-31(ϩ) animals, obtained three transgenic lines, and
found that an average of 42% of animals exhibited a
dominant Vul phenotype ( Figure 4C and Table 1 ). We
then directly determined the pattern of cell fates ex-
pressed by P5.p, P6.p, and P7.p in these animals and again found that these cells often adopted uninduced
or defective cell fates (Table 2) . These results suggest
that LIN-31(PhD) can act to diminish the mpk-1 signaling
pathway in the vulva, perhaps by remaining complexed
with LIN-1.
We also microinjected DNA containing lin-31(PhD) 
LIN-31(VP16) Promotes Vulval Cell Fates
In addition to inhibiting vulval cell fates in P3.p, P4.p, and P8.p, genetic analysis suggests that LIN-31 WH Although our biochemical studies indicate that phosphorylation greatly reduces LIN-1/LIN-31 binding, some promotes the expression of vulval fates in P5.p, P6.p, and P7.p. MPK-1 is active in P6.p (and possibly P5.p binding is still observed at high protein concentrations (P. B. T., unpublished observations). The close proximity and P7.p as well), suggesting that LIN-31 may be phosphorylated in these cells. How might phosphorylation of LIN-1 and LIN-31 sequences in the forced heterodimer might permit binding interactions to occur even of LIN-31 allow it to promote vulval induction? In many cases, the phosphorylation of a transcription factor by a when these proteins are phosphorylated. We injected this construct into lin-31(ϩ); lin-1(ϩ) animals, obtained MAP kinase creates or reveals a potent trans-activation domain (Treisman, 1996) . This might also be the case six transgenic lines, and observed that 10%-50% of the transgenic animals exhibited a dominant Vul phenotype for LIN-31 WH, especially since the middle region of LIN-31 that contains the LIN-1-binding site also contains ( Figure 4B and Table 1 ). In contrast, transgenic lines that expressed either lin-31 or lin-1 alone did not exhibit a putative LIN-31 trans-activation domain and a MPK-1 phosphorylation site. To pursue this possibility, we rethis effect, indicating that the vulvaless phenotype of LIN-1::LIN-31 animals is not likely to be due to overexplaced both the phosphorylation domain and the LIN-1-binding region of LIN-31 with a strong trans-activation pression of either lin-31 or lin-1 ( Figure 4A and Table 1) .
We then used Nomarski microscopy to determine the domain (VP16), reasoning that this might be functionally analogous to constitutive phosphorylation by MPK-1. pattern of vulval precursor cell division in animals expressing LIN-1::LIN-31. We observed that in these aniWe injected DNA containing lin-31(VP16) into lin-31(ϩ) animals, generated four transgenic lines, and found that mals, P5.p, P6.p, and P7.p (which normally express 1Њ or 2Њ vulval fates) often expressed nonvulval 3Њ cell fates 10%-30% of the animals from these transgenic lines exhibited a dominant Muv phenotype ( Figure 4D ). As a (Table 2 ). These lineage patterns are similar to the phenotype caused by mutations that diminish the activity control, we also engineered a construct that expressed only the DNA-binding region of LIN-31, introduced this of the vulval signaling pathway, such as mutations in lin-3 EGF, let-23 receptor, let-60 Ras, or mpk-1 (Kornconstruct into lin-31(ϩ) mutants, and generated five transgenic lines. We found that expression of the LINfeld, 1997). Thus, these results suggest that preventing dissociation of LIN-1 from LIN-31 blocks vulval in-31 DNA-binding region alone did not result in a dominant Muv phenotype (Table 1 ), indicating that the effects of duction. Figure 5A ). Since activation of MPK-1 is thought to occur during this time (Kimble, genic lines is significantly higher than that of lin-31 null mutants (Table 1) , again suggesting that 1981; Euling and Ambros, 1996) , these results show that LIN-31 is present in the vulval precursor cells at the promotes the expression of vulval cell fates.
Taken together, these results indicate that LIN-31(VP16) appropriate time and place to respond to activated MPK-1. causes the vulval precursor cells to express vulval cell
The mpk-1 signaling pathway is used in the vulva, the fates. The simplest interpretation of these results is that germline, and the sex myoblasts (Church et al., 1995; LIN-31(VP16) well. Finally, the let-23 receptor signaling pathway also acts to establish the fate of P12 in the posterior ectoderm (Aroian and Sternberg, 1991; P. Sternberg, personal communication) , and mpk-1 may function in this cell as well.
Two pieces of evidence suggest that lin-31 interacts with the mpk-1 signaling pathway only in the vulva and not in other tissues. First, LIN-31 protein is expressed primarily in the vulval precursor cells and not in these other tissues. We did not detect LIN-31 expression in the germline, P12 (the posterior ectoderm), and the sex myoblasts ( Figures 5C-5E , data not shown). LIN-31 is also not expressed in the excretory system at the appropriate time to respond to mpk-1 signaling. mpk-1 signaling in the excretory system probably occurs before or during the mid L1 larval stage, as larval lethality caused by loss-of-function mutations in the let-23 signaling pathway occurs at this time (Aroian and Sternberg, 1991; Yochem et al., 1997 ; M. R. L. and S. K. K., unpublished data). We then determined the LIN-31 expression pattern in wild-type animals at the same developmental stage as arrested let-23 mutant larvae, and we found that LIN-31 is not expressed in the excretory duct cell of wild-type animals at this stage ( Figures 5E and 5F ). Intriguingly, we observed LIN-31 expression in this cell later, in the mid L2 stage ( Figure 5A ).
Second, lin-31 and mpk-1 exhibit similar mutant phenotypes only in vulval induction. Specifically, lin-31 mutants exhibit defects in vulval cell fate specification but do not exhibit apparent phenotypes in the excretory system, sex myoblasts, germline, or posterior ectoderm (Miller et al., 1993; Sundaram et al., 1996 ; P. B. T., unpublished observations).
In addition to its role in vulval development, lin-31 functions in the development of the male tail. However, the function of lin-31 in this tissue is likely to be different from that of the mpk-1 signaling pathway. The mpk-1 signaling pathway is thought to act in the male tail to specify the fate of four cells that arise from the B cell lineage (B.a[l or r]pp, B.alap, B.arap, and B.a[l or r]aa) (Chamberlin and Sternberg, 1994) . LIN-31 is expressed in three of these four cells (all except B.a[l or r]aa) ( Figure  5G ). However, the lin-31 male tail phenotype is distinctly different from the let-23 receptor and let-60 Ras mutant phenotype (S. Baird, personal communication). The defective mating spicules of lin-31 males result from the issue.
In summary, these genetic and expression studies suggest that lin-31 does not interact with the mpk-1 most likely does not interact with this pathway in male signaling pathway in the germline, the posterior ectotail development to specify the fates of the B cell progeny. LIN-31 WH may thus act as a vulval-specific effector derm, the sex myoblasts, or the excretory system and of mpk-1 signaling and contribute to the signaling specificity of the MPK-1 signaling pathway.
Ectopic Expression of LIN-31 Causes P12 to Express a Vulval-Specific Marker
We wanted to determine whether ectopic expression of LIN-31 in another let-23 receptor-responsive cell type might partially induce that cell to express vulval-specific markers in response to let-23 signaling. One such marker is increased LET-23 RTK expression, since staining with ␣-LET-23 antibodies shows that LET-23 RTK expression sharply increases in P6.p ( Figure 6A ; Simske et al., 1996) . This feedback regulation is thought to be important for vulval patterning, as high LET-23 RTK levels may bind and sequester LIN-3 and thereby prevent LIN-3 from inducing other vulval precursor cells (Hajnal et al., 1997) . Increased expression of LET-23 RTK is a vulval-specific event, because LET-23 RTK expression does not increase in the P12 posterior ectoblast, when the let-23 signaling pathway functions to specify the P12 fate ( Figure 6C ).
We found that lin-31 is required to increase LET-23 RTK expression in P6.p. In lin-31 null mutants, we detected increased LET-23 RTK expression in P6.p in only 46% of lin-31 null mutants (n ϭ 50) versus 100% of wild-type animals (n ϭ 50) ( Figure 6B ). Thus, lin-31 is necessary for the accurate and fidelitous execution of positive LET-23 RTK expression in P6.p.
Next, we tested whether ectopic expression of lin-31 in P12 could cause it to express this vulval specific marker. A heat-shock promoter was used to ectopically express LIN-31 in P12 during the time of P12 specification. We detected increased LET-23 RTK expression in P12 in 33% of heat-shocked animals (n ϭ 12) but no increased expression in any wild-type (n ϭ 15) or heatshocked control animals (n ϭ 20) ( Figure 6D ). These results demonstrate that lin-31 functions as a vulvalspecific effector of let-23 signaling, as lin-31 misexpression causes a heterologous let-23 responsive cell to express a vulval-specific marker (increased LET-23 RTK expression). where MAP kinase is inactive (P3.p, P4.p, and P8.p), the mpk-1 signal specifically in the vulva, while LIN-1 may act as a more general effector of this signaling pathway. In addition, regional LIN-31 and LIN-1 are associated as a complex that inhibexpression of Hox genes may also impart specificity to this signaling its vulval induction, resulting in these vulval precursor pathway (Maloof and Kenyon, 1998 Figure 7A) . Instead, these genes would be vulval induction, then a strain in which LIN-1 is always transcribed at an intermediate or basal level, which associated with LIN-31 should be Vul. We engineered a might also be near the threshold for vulval induction. gene that expresses a LIN-1::LIN-31 forced heterodimer, Consequently, stochastic variation in the expression levsimilar to that reported for the bHLH factors MyoD and els of these LIN-31 target genes would eventually cause E47 (Neuhold and Wold, 1993 cifically, the products of these LIN-31 target genes might can function to inhibit vulval induction in P3.p, P4.p, and positively regulate their own expression and negatively P8.p. In these cells in wild-type animals, MAP kinase is cross-regulate genes promoting the alternative cell fate most likely inactive, and LIN-31(ϩ) is most likely unphos- (Miller et al., 1993) . In this model, if these postulated phorylated. Thus, LIN-31(PhD) retains the function asso-LIN-31 target genes were initially expressed above a ciated with unphosphorylated LIN-31(ϩ). However, lincertain threshold, then these feedback loops could am-31(PhD) does not rescue the Vul phenotype of a lin-31 plify their own expression and cause the vulval precursor null mutant, indicating that LIN-31(PhD) does not retain cell to adopt a discrete 1Њ or 2Њ cell fate. If the initial the function associated with phosphorylated LIN-31 (in level were lower than a certain threshold, then these P6.p and possibly P5.p and P7.p). These results suggest feedback loops would not be maintained and such a that LIN-31 is phosphorylated in vivo and that this phosvulval precursor cell would express the 3Њ cell fate. Simiphorylation determines whether vulval precursor cells lar mechanisms have been proposed to explain how express vulval or nonvulval cell fates. small qualitative differences can be amplified to yield Third, if MAP kinase phosphorylation results in dissodistinct biological responses in the life cycle of phage ciation of the LIN-1/LIN-31 inhibitor complex and actiand in the process of Drosophila sex determination vates a LIN-31 trans-activation domain, then replacing (Ptashne et al., 1980; Bell et al., 1991) . the LIN-1 binding region of LIN-31 with the VP16 trans-A key implication of this model is that in wild-type activation domain should be functionally analogous to animals, LIN-31 target genes are either strongly activated constitutive LIN-31 phosphorylation. This is because the or repressed. Recent reports suggest that many diverse VP16 trans-activation domain should not bind to LIN-1 transcription factors (such as Mad, CREB, c-Jun, NFand should function as a trans-activation domain inde-B, and the various nuclear hormone receptors) can pendently of MAP kinase phosphorylation. As predicted, both activate and repress transcription, depending upon we found that a transgene expressing a lin-31(VP16) their association with corepressors (such as SMRT or chimeric activator caused a dominant Muv phenotype. mSin3a) or coactivators (such as SRC-1, ACTR, and This result suggests that the activation of LIN-31 target CBP) (reviewed in Horwitz et al., 1996) . The results of genes is sufficient to cause vulval precursor cells to this work show how an activation/repression mechaexpress vulval cell fates ectopically.
Discussion
nism can be used in a developmental patterning context. Our work does not address the functional conse-LIN-31 can both positively and negatively regulate vulval quences of MAP kinase phosphorylation of LIN-1. lin-1 induction, and both functions are required for the proper loss-of-function mutations do not obviously affect the spatial specification of vulval cell fates. Vulval precursor specification of vulval cell fates by P5.p, P6.p, and P7.p cells are not fully activated if the positive function is (Beitel et al., 1995) , unlike mutations in lin-31. Phosphordefective (resulting in a Vul phenotype), and they are ylation of LIN-1 may thus inactivate its inhibitory function. Alternatively, LIN-1 phosphorylation may not be not fully inhibited if the negative function is defective
